Season 5, Episode 4 (Switching between JAKI's, Ritlecitinib in Adolescents, VTE Risk in AT/AU)

The Evidence Based Hair Podcast was created by dermatologist & hair loss specialist Dr Jeff Donovan to highlight new, hot off the press, world-class research in the field of hair loss. The podcast was created for hair loss practitioners around the world who care for patients with all different types of hair loss. Each week, different hair loss research topics are covered in the podcast including new research related to androgenetic alopecia, alopecia areatea, telogen effluvium, traction alopecia, tinea capitis, trichotillomania, chemotherapy induced hair loss, lichen planopilaris, frontal fibrosing alopecia, dissecting cellulitis, folliculitis decalvans, discoid lupus, central centrifugal cicatricial alopecia, erosive pustular dermatosis.... and a whole lot more.
STUDIES REFERENCE IN THIS EPISODE
SWITCHING FROM TOFACITINIB TO BARICITINIB
Kazmi A et al (starts at 13:24). Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response. J Am Acad Dermatol. 2023 Apr 4;S0190-9622(23)00532-7.
RITLECITINIB IN ADOLESCENTS
Hordinsky M et al (starts at 23:08). Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial. Pediatr Dermatol. 2023 Jul 17.
King B et al (starts at 25:25) Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial. Lancet. 2023 May 6;401(10387):1518-1529.
RISK OF INFECTIONS, CANCER, HEART DISEASE AND BLOOD CLOTS IN AT/AU
George P et al (starts at 38:41). Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database., Dermatol Ther (Heidelb). 2023 Aug; 13(8): 1733-1746.
Schneeweiss MC et al (starts at 40:33). Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2021 Jul 1;157(7):805-816.
MARKERS OF VENOUS THROMBOEMBOLISM IN ALOPECIA AREATA
Sudnik W et al (starts at 1:01:29) . The role of selectins in alopecia areata. Postepy Dermatol Alergol. 2015 Feb;32(1):27-32.
Shakoei S et al (starts at 1:02:12). Coagulation status in patients with alopecia areata: a cross-sectional study. Ital J Dermatol Venerol. 2021 Oct;156(5):588-592.
Waśkiel-Burnat A et al (starts at 1:03:25). Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about? Dermatol Ther (Heidelb). 2023 Aug;13(8):1847-1855.
HABIT REPLACEMENT THERAPY FOR TRICHOTILLOMANIA
Moritz S et al (starts at 1:08:50). Self-Help Habit Replacement in Individuals With Body-Focused Repetitive Behaviors: A Proof-of-Concept Randomized Clinical Trial. JAMA Dermatol. 2023 Jul 19;e232167.
LINK TO VIDEO on HRT DEMONSTRATION
clinical-neuropsychology.de/h...

Пікірлер: 2

  • @nurDerHSV857
    @nurDerHSV85711 ай бұрын

    That's what scares me so much, I have about 98% regrowth(with Tofacitinib after 6Month;had 90% hairloss) and I'm afraid to lose it all again after 1-2 years.😒

  • @donovanmedical9780

    @donovanmedical9780

    11 ай бұрын

    So many patients with stories like yours are doing really well with longer term follow up. There is good reason to be hopeful for continued good growth. Thanks for sharing and best wishes!

Келесі